Study S002050

Pharmacological Treatment - An Overview of Its Role in Managing Childhood Obesity

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07304141
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 128
Start: 2023-12-20
Primary completion: 2025-12-12
Lead sponsor: Göteborg University
Conditions: Obesity (Disorder); Child Obesity
Interventions: OTHER:Liraglutide 3 mg (Saxenda)
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Change in Body Mass Index Standard Deviation Score (BMI SDS) over time [The primary outcome, change in BMI SDS, will be evaluated at -12 months (pre-baseline), at baseline (0 months), and at +3-6, +12, and +18 months following treatment initiation.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.